Local and systemic effects of angiotensin receptor blockade in an emphysema mouse model

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 2, 2011, Pages 215-220

  Raupach, Tobias ^a   Lüthje, Lars ^a   Kögler, Harald ^a   Duve, Christian ^a   Schweda, Frank ^b   Hasenfuß, Gerd ^a   Andreas, Stefan ^a,c  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Lungenfachklinik Immenhausen   (Germany)

Author keywords

Angiotensin; Animal model; Emphysema; Neurohumoral activation

Indexed keywords

IRBESARTAN; NORADRENALIN; PANCREATIC ELASTASE; PHOSPHATE BUFFERED SALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; EXERCISE TOLERANCE; FEMALE; FOOD INTAKE; HISTOPATHOLOGY; HORMONAL REGULATION; LUNG COMPLIANCE; LUNG EMPHYSEMA; LUNG FUNCTION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREADMILL EXERCISE; TREATMENT DURATION; WEIGHT REDUCTION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIOMECHANICS; BIPHENYL COMPOUNDS; DISEASE MODELS, ANIMAL; EXERCISE TOLERANCE; FEMALE; MICE; PANCREATIC ELASTASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SEVERITY OF ILLNESS INDEX; SWINE; TETRAZOLES;

EID: 79951944322     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2010.12.006     Document Type: Article

References (49)

1. Demedts I.K., Demoor T., Bracke K.R., Joos G.F., Brusselle G.G. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006, 7:53.
2. Hogg J.C., Chu F., Utokaparch S., Woods R., Elliott W.M., Buzatu L., et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653.
3. Ingenito E.P., Tsai L.W., Majumdar A., Suki B. On the role of surface tension in the pathophysiology of emphysema. Am J Respir Crit Care Med 2005, 171:300-304.
4. The definition of emphysema. Am Rev Respir Dis 1985, 132:182-185. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop.
5. Hogg J.C., Wright J.L., Wiggs B.R., Coxson H.O., Opazo Saez A., Pare P.D. Lung structure and function in cigarette smokers. Thorax 1994, 49:473-478.
6. Yuan R., Hogg J.C., Pare P.D., Sin D.D., Wong J.C., Nakano Y., et al. Prediction of the rate of decline in FEV(1) in smokers using quantitative computed tomography. Thorax 2009, 64:944-949.
7. Barnes P.J., Celli B.R. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009, 33:1165-1185.
8. Vonk-Noordegraaf A. The shrinking heart in chronic obstructive pulmonary disease. N Engl J Med 2010, 362:267-268.
9. Reid M.B. COPD as a muscle disease. Am J Respir Crit Care Med 2001, 164:1101-1102.
10. Raupach T., Bahr F., Herrmann P., Luthje L., Hasenfuss G., Andreas S. Inspiratory resistive loading does not increase sympathetic tone in COPD. Respir Med 2010, 104:107-113.
11. Raupach T., Bahr F., Herrmann P., Luethje L., Heusser K., Hasenfuss G., et al. Slow breathing reduces sympathoexcitation in COPD. Eur Respir J 2008, 32:387-392.
12. Heindl S., Lehnert M., Criée C.P., Hasenfuß G., Andreas S. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 2001, 164:597-601.
13. Andreas S., Anker S.D., Scanlon P.D., Somers V.K. Neurohumoral activation as a link to systemic manifestation of chronic lung disease. Chest 2005, 128:3618-3624.
14. Luthje L., Raupach T., Michels H., Unsold B., Hasenfuss G., Kogler H., et al. Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model. Respir Res 2009, 10:7.
15. Mancini G.B. The 'double dip' hypothesis: simultaneous prevention of cardiovascular and pulmonary morbidity and mortality using angiotensin II type 1 receptor blockers. Can J Cardiol 2005, 21:519-523.
16. Llorens-Cortes C., Greenberg B., Huang H., Corvol P. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 1994, 24:538-548.
17. Wang R., Zagariya A., Ibarra-Sunga O., Gidea C., Ang E., Deshmukh S., et al. Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am J Physiol 1999, 276:L885-L889.
18. Molteni A., Ward W.F., Ts'ao C.H., Taylor J., Small W., Brizio-Molteni L., et al. Cytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptor antagonists. Curr Pharm Des 2003, 9:751-761.
19. Wosten-van Asperen R.M., Lutter R., Haitsma J.J., Merkus M.P., van Woensel J.B., van der Loos C.M., et al. ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin. Eur Respir J 2008, 31:363-371.
20. Esler M. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function. J Hypertens 2002, 20(Suppl. 5):S13-S19.
21. Kawamura A., Yuasa F., Yokoe H., Masue Y., Sugiura T., Iwasaka T. Augmented sympathoinhibitory effect of valsartan when added to angiotensin-converting enzyme inhibitor in patients with left ventricular dysfunction. J Cardiol 2009, 53:171-178.
22. Andreas S., Herrmann-Lingen C., Raupach T., Luthje L., Fabricius J.A., Hruska N., et al. Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial. Eur Respir J 2006, 27:972-979.
23. Mortensen E.M., Copeland L.A., Pugh M.J., Restrepo M.I., de Molina R.M., Nakashima B., et al. Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir Res 2009, 10:45.
24. Di Marco F., Guazzi M., Vicenzi M., Santus P., Cazzola M., Pappalettera M., et al. Effect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease: a pilot study. Pulm Pharmacol Ther 2010, 23:159-164.
25. Gardi C., Cavarra E., Calzoni P., Marcolongo P., de Santi M., Martorana P.A., et al. Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors. Biochem J 1994, 299(Pt 1):237-245.
26. Dunnill M.S. Evaluation of a simple method of sampling the lung for quantitative histological analysis. Thorax 1964, 19:443-448.
27. Wagner C., Kurtz L., Schweda F., Simon A.M., Kurtz A. Connexin 37 is dispensable for the control of the renin system and for positioning of renin-producing cells in the kidney. Pflugers Arch 2009, 459:151-158.
28. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
29. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes de Oca M., Mendez R.A., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:1005-1012.
30. Pinto-Plata V.M., Cote C., Cabral H., Taylor J., Celli B.R. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004, 23:28-33.
31. Wright J.L., Cosio M., Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2008, 295:L1-L15.
32. Morris D.G., Sheppard D. Pulmonary emphysema: when more is less. Physiology (Bethesda) 2006, 21:396-403.
33. Dawkins P.A., Stockley R.A. Animal models of chronic obstructive pulmonary disease. Thorax 2001, 56:972-977.
34. Shapiro S.D. Animal models for chronic obstructive pulmonary disease: age of klotho and marlboro mice. Am J Respir Cell Mol Biol 2000, 22:4-7.
35. Snider G.L., Sherter C.B. A one-year study of the evolution of elastase-induced emphysema in hamsters. J Appl Physiol 1977, 43:721-729.
36. Houghton A.M., Quintero P.A., Perkins D.L., Kobayashi D.K., Kelley D.G., Marconcini L.A., et al. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 2006, 116:753-759.
37. Lucey E.C., Keane J., Kuang P.P., Snider G.L., Goldstein R.H. Severity of elastase-induced emphysema is decreased in tumor necrosis factor-alpha and interleukin-1beta receptor-deficient mice. Lab Invest 2002, 82:79-85.
38. Hunninghake G.M., Cho M.H., Tesfaigzi Y., Soto-Quiros M.E., Avila L., Lasky-Su J., et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med 2009, 361:2599-2608.
39. Tuder R.M., Petrache I., Elias J.A., Voelkel N.F., Henson P.M. Apoptosis and emphysema: the missing link. Am J Respir Cell Mol Biol 2003, 28:551-554.
40. Suki B., Lutchen K.R., Ingenito E.P. On the progressive nature of emphysema: roles of proteases, inflammation, and mechanical forces. Am J Respir Crit Care Med 2003, 168:516-521.
41. Karrasch S., Holz O., Jorres R.A. Aging and induced senescence as factors in the pathogenesis of lung emphysema. Respir Med 2008, 102:1215-1230.
42. Filippatos G., Tilak M., Pinillos H., Uhal B.D. Regulation of apoptosis by angiotensin II in the heart and lungs (review). Int J Mol Med 2001, 7:273-280.
43. Papp M., Li X., Zhuang J., Wang R., Uhal B.D. Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II. Am J Physiol Lung Cell Mol Physiol 2002, 282:L713-L718.
44. Tanaka H., Teramoto S., Oashi K., Saikai T., Tanaka S., Suzuki K., et al. Effects of candesartan on cough and bronchial hyperresponsiveness in mildly to moderately hypertensive patients with symptomatic asthma. Circulation 2001, 104:281-285.
45. Hoymann H.G. Invasive and noninvasive lung function measurements in rodents. J Pharmacol Toxicol Methods 2007, 55:16-26.
46. Irvin C.G., Bates J.H. Measuring the lung function in the mouse: the challenge of size. Respir Res 2003, 4:4.
47. Fujita M., Ye Q., Ouchi H., Nakashima N., Hamada N., Hagimoto N., et al. Retinoic acid fails to reverse emphysema in adult mouse models. Thorax 2004, 59:224-230.
48. Weibel E.R., Hsia C.C., Ochs M. How much is there really? Why stereology is essential in lung morphometry. J Appl Physiol 2007, 102:459-467.
49. Rangasamy T., Misra V., Zhen L., Tankersley C.G., Tuder R.M., Biswal S. Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression. Am J Physiol Lung Cell Mol Physiol 2009, 296:L888-L900.